Editorial
Are Three Lung Function Risk Markers Better Than One?
Respirology · 2026-11 · 31 (11) · 1060-1061
DOI: 10.1002/resp.70313 ↗At a glance
Editorial in Respirology, published online on 2026-09-20. Written by Rosa Faner. Institution: Biomedicine Department, University of Barcelona, Barcelona, Spain. 11 references. Funded by: Instituto de Salud Carlos III, Fondos FEDER una manera de hacer Europa, Institució Catalana de Recerca i Estudis Avançats.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
COPDairflow limitationlung functionsmall airway dysfunction
Authors and institutions
- Biomedicine Department, University of Barcelona, Barcelona, Spain.
- Fundació Clínic per la Recerca Biomèdica (FCRB) - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Madrid, Spain.
ORCID profiles: Rosa Faner
Funding
- Instituto de Salud Carlos III
- Fondos FEDER una manera de hacer Europa
- Institució Catalana de Recerca i Estudis Avançats
- European Research Council
Cite
APA
Faner, R. (2026). Are Three Lung Function Risk Markers Better Than One?. Respirology, 31(11), 1060-1061. https://doi.org/10.1002/resp.70313
Vancouver
Faner R. Are Three Lung Function Risk Markers Better Than One?. Respirology. 2026;31(11):1060-1061. doi:10.1002/resp.70313
BibTeX
@article{Faner2026,
author = {Faner, Rosa},
title = {Are Three Lung Function Risk Markers Better Than One?},
journal = {Respirology},
year = {2026},
volume = {31},
number = {11},
pages = {1060--1061},
doi = {10.1002/resp.70313}
}
EUVIMED